1. A cutoff thyroglobulin value suggestive of distant metastases in differentiated thyroid cancer patients
- Author
-
J.S. Couto, M.F.O. Almeida, V.C.G. Trindade, M.M.S. Marone, N.M. Scalissi, A.N. Cury, C. Ferraz, and R.P. Padovani
- Subjects
Thyroid cancer ,Stimulated thyroglobulin ,Cutoff point ,High risk ,Distant metastasis ,Medicine (General) ,R5-920 ,Biology (General) ,QH301-705.5 - Abstract
Serum thyroglobulin is used as part of the early postoperative assessment of differentiated thyroid cancer (DTC) since there is a clear relationship between an increased risk of recurrence and persistent disease after initial treatment and high postoperative stimulated thyroglobulin (ps-Tg) values. Thus, although ps-Tg above 10–30 ng/mL is considered an independent predictor of worse prognosis, the value that is associated with distant metastases is not defined. Thus, this was our objective. We selected 655 DTC patients from a nuclear medicine department database (Irmandade Santa Casa de Misericórdia de São Paulo, Brazil). All patients had received total thyroidectomy and radioactive iodine (RAI) therapy and had ps-Tg values higher than 10 ng/mL with negative anti-thyroglobulin antibodies. Then, we selected patients who presented post-therapy whole-body scan with pulmonary and/or bone uptake but with no mediastinum or cervical uptake. Patients with negative findings on functional imaging or any doubt on lung/bone uptake were submitted to additional exams to exclude another non-thyroid tumor. Of the 655 patients, 14.3% had pulmonary and 4.4% bone metastases. There was a significant difference in ps-Tg levels between patients with and without metastases (P
- Published
- 2020
- Full Text
- View/download PDF